Immunotherapy: Open Access

Immunotherapy: Open Access
Open Access

ISSN: 2471-9552

+44 1223 790975

Breast Cancer Immunotherapy

Breast Cancer Immunotherapy holds many advantages over targeted treatments and conventional chemotherapy directed at the tumor itself. Drug in breast cancer immunotherapy is Herceptin.

It targets breast tumors that produce a protein called HER2. The side effects of this therapy are chills, pain, weakness, nausea, vomiting, diarrhoea. It mostly involves surgery depending upon its state and molecular characteristics.

Related Journals of Breast Cancer Immunotherapy

Immunotherapy: Open Access, Immunome Research journal, Immunology Journal, Immunooncology journal, Immunobiology journal, Therapeutic Advances in Medical Oncology, MAEDICA – A Journal of Clinical Medicine, Immunology & Cell Biology, Annals of Oncology, Future Oncology.

High Impact List of Articles
Conference Proceedings